D. E. Shaw & Co., Inc. Global Blood Therapeutics, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $53,508 - $78,414	2,100 Added 11.73%	20,000 $510,000
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $141,317 - $237,277	2,900 Added 19.33%	17,900 $1.13 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $473,100 - $700,050	15,000 New	15,000 $616,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.